Bristol Myers Squibb (BMY) Common Equity (2009 - 2026)
Bristol Myers Squibb (BMY) reported Common Equity of $20.1 billion for Q1 2026, up 24.81% year-over-year from $16.1 billion in Q1 2025, and up 8.62% on a QoQ basis from $18.5 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Common Equity data on file, last reported at $20.1 billion in Q1 2026.
- Quarterly Common Equity rose 24.81% year-over-year to $20.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 billion (up 24.81% YoY) and the FY2025 annual result came in at $18.5 billion, up 24.1% from the prior year.
- Common Equity advanced to $20.1 billion in Q1 2026 per BMY's latest filing, from $18.5 billion in the prior quarter.
- Across five years, Common Equity topped out at $46.1 billion in Q2 2025 and bottomed at -$43.7 billion in Q2 2024.
- The 5-year median for Common Equity is $16.1 billion (2025), against an average of $15.1 billion.
- The widest annual swing landed in 2023, when Common Equity surged 80047.37%; it then sank 196.45% in 2024.
- Tracing BMY's Common Equity over 5 years: stood at $57.0 million in 2022, then surged by 80047.37% to $45.7 billion in 2023, then tumbled by 67.36% to $14.9 billion in 2024, then climbed by 24.1% to $18.5 billion in 2025, then rose by 8.62% to $20.1 billion in 2026.
- Per Business Quant, the three latest BMY Common Equity figures stand at $20.1 billion (Q1 2026), $18.5 billion (Q4 2025), and $18.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 31.20 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 81.19 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -6.61 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 45.93 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 9.19 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 23.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 90.40 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 20.10 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 21.78 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.10 Bn |
| Dec 31, 2025 | 18.51 Bn |
| Sep 30, 2025 | 18.55 Bn |
| Jun 30, 2025 | 46.13 Bn |
| Mar 31, 2025 | 16.11 Bn |
| Dec 31, 2024 | 14.91 Bn |
| Sep 30, 2024 | 45.90 Bn |
| Jun 30, 2024 | -43.69 Bn |
| Mar 31, 2024 | 292.00 Mn |
| Dec 31, 2023 | 45.68 Bn |
| Sep 30, 2023 | 28.22 Bn |
| Jun 30, 2023 | 45.30 Bn |
| Mar 31, 2023 | 62.00 Mn |
| Dec 31, 2022 | 57.00 Mn |
| Sep 30, 2022 | 63.00 Mn |
| Jun 30, 2022 | 292.00 Mn |
| Mar 31, 2022 | 65.00 Mn |
| Dec 31, 2021 | 23.82 Bn |
| Sep 30, 2021 | -1.42 Bn |
| Jun 30, 2021 | -28.20 Bn |
| Mar 31, 2021 | -1.54 Bn |
| Dec 31, 2020 | -1.84 Bn |
| Sep 30, 2020 | 50.23 Bn |
| Jun 30, 2020 | 49.16 Bn |
| Mar 31, 2020 | 49.98 Bn |
| Dec 31, 2019 | 100.00 Mn |
| Sep 30, 2019 | 17.75 Bn |
| Jun 30, 2019 | 16.15 Bn |
| Mar 31, 2019 | 15.32 Bn |
| Dec 31, 2018 | -19.57 Bn |
| Sep 30, 2018 | 13.75 Bn |
| Jun 30, 2018 | 12.42 Bn |
| Mar 31, 2018 | 12.91 Bn |
| Dec 31, 2017 | 11.74 Bn |
| Sep 30, 2017 | 14.91 Bn |
| Jun 30, 2017 | 14.82 Bn |
| Mar 31, 2017 | 14.54 Bn |
| Dec 31, 2016 | 16.35 Bn |
| Sep 30, 2016 | 15.78 Bn |
| Jun 30, 2016 | 15.08 Bn |
| Mar 31, 2016 | 14.55 Bn |
| Dec 31, 2015 | 14.27 Bn |
| Sep 30, 2015 | 15.27 Bn |
| Jun 30, 2015 | 15.29 Bn |
| Mar 31, 2015 | 15.69 Bn |
| Dec 31, 2014 | 14.85 Bn |
| Sep 30, 2014 | 15.20 Bn |
| Jun 30, 2014 | 15.38 Bn |
| Mar 31, 2014 | 15.53 Bn |
| Dec 31, 2013 | 15.24 Bn |
| Sep 30, 2013 | 14.71 Bn |
| Jun 30, 2013 | 14.37 Bn |
| Mar 31, 2013 | 13.70 Bn |
| Dec 31, 2012 | 13.64 Bn |
| Sep 30, 2012 | 13.90 Bn |
| Jun 30, 2012 | 15.81 Bn |
| Mar 31, 2012 | 16.25 Bn |
| Dec 31, 2011 | 15.96 Bn |
| Sep 30, 2011 | 16.44 Bn |
| Jun 30, 2011 | 16.15 Bn |
| Mar 31, 2011 | 15.90 Bn |
| Dec 31, 2010 | 15.71 Bn |
| Dec 31, 2009 | 14.84 Bn |
| Sep 30, 2009 | 14.37 Bn |
| Jun 30, 2009 | 13.94 Bn |